Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |